{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:17:28Z","timestamp":1794284248602,"version":"4.9.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Department of Science and Technology of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ50442"],"award-info":[{"award-number":["2023JJ50442"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.clgc.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T20:36:56Z","timestamp":1687466216000},"page":"537-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Yueji","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-3102","authenticated-orcid":false,"given":"Xiao-Liang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2023.06.011_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2023.06.011_bib0002","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The cancer genome atlas of renal cell carcinoma: findings and clinical implications","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clgc.2023.06.011_bib0004","doi-asserted-by":"crossref","first-page":"427","DOI":"10.21037\/atm.2019.08.113","article-title":"Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.clgc.2023.06.011_bib0005","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7150\/jca.38274","article-title":"Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer","volume":"11","author":"Cao","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.clgc.2023.06.011_bib0006","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.07.011","article-title":"Epigenetic alterations in colorectal cancer: emerging biomarkers","volume":"149","author":"Okugawa","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clgc.2023.06.011_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/15592294.2014.1003746","article-title":"Epigenetic regulation in human melanoma: past and future","volume":"10","author":"Sarkar","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/j.clgc.2023.06.011_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1804-1_1","article-title":"Cancer epigenetics: an introduction","volume":"1238","author":"Kanwal","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0009","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-020-01379-5","article-title":"Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.clgc.2023.06.011_bib0010","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/bjc.1997.64","article-title":"Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis","volume":"75","author":"Cheng","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2023.06.011_bib0011","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/onc.2011.307","article-title":"DNA hypermethylation in lung cancer is targeted at differentiation-associated genes","volume":"31","author":"Helman","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.clgc.2023.06.011_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2020.08.002","article-title":"Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma","volume":"246-247","author":"Cai","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.clgc.2023.06.011_bib0013","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/resp.12789","article-title":"Immunotherapy for lung cancer","volume":"21","author":"Steven","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.clgc.2023.06.011_bib0014","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/cco.2018.05.05","article-title":"Immunotherapy for metastatic breast cancer","volume":"7","author":"Sugie","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.trecan.2018.04.001","article-title":"Immunotherapy and prevention of pancreatic cancer","volume":"4","author":"Morrison","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.clgc.2023.06.011_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072532","article-title":"Immunotherapy in renal cell carcinoma: the future is now","volume":"21","author":"Deleuze","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clgc.2023.06.011_bib0017","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clgc.2023.06.011_bib0018","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clgc.2023.06.011_bib0019","doi-asserted-by":"crossref","first-page":"R10","DOI":"10.1186\/gb-2011-12-1-r10","article-title":"DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines","volume":"12","author":"Bell","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0020","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","volume":"3","author":"Hsieh","year":"2017","journal-title":"Renal cell carcinoma. Nat Rev Dis Primers"},{"key":"10.1016\/j.clgc.2023.06.011_bib0021","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.201608024","article-title":"VHL promotes immune response against renal cell carcinoma via NF-kappaB-dependent regulation of VCAM-1","volume":"216","author":"Labrousse-Arias","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0022","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1007\/s13277-015-4339-5","article-title":"Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"37","author":"Park","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12885-017-3369-3","article-title":"Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy","volume":"17","author":"Nukui","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2023.06.011_bib0024","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejmech.2016.10.037","article-title":"New approach of delivering cytotoxic drugs towards CAIX expressing cells: a concept of dual-target drugs","volume":"127","author":"van Kuijk","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.clgc.2023.06.011_bib0025","doi-asserted-by":"crossref","first-page":"42086","DOI":"10.18632\/oncotarget.9669","article-title":"Opposite prognostic roles of HIF1alpha and HIF2alpha expressions in bone metastatic clear cell renal cell cancer","volume":"7","author":"Szendroi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clgc.2023.06.011_bib0026","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/00029330-200812020-00003","article-title":"Screening of tumor suppressor genes on 1q31.1-32.1 in Chinese patients with sporadic colorectal cancer","volume":"121","author":"Zhou","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.clgc.2023.06.011_bib0027","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.3892\/ol.2016.4976","article-title":"Celecoxib exhibits an anti-gastric cancer effect by targeting focal adhesion and leukocyte transendothelial migration-associated genes","volume":"12","author":"Jin","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clgc.2023.06.011_bib0028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000100475","article-title":"Methylation status of genes upregulated by demethylating agent 5-aza-2\u2032-deoxycytidine in hepatocellular carcinoma","volume":"71","author":"Hirasawa","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.clgc.2023.06.011_bib0029","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12935-020-01179-x","article-title":"Expression profile analysis identifies key genes as prognostic markers for metastasis of osteosarcoma","volume":"20","author":"Guan","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.clgc.2023.06.011_bib0030","doi-asserted-by":"crossref","first-page":"7667","DOI":"10.1158\/1078-0432.CCR-08-0479","article-title":"Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer","volume":"14","author":"Callahan","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2023.06.011_bib0031","first-page":"816","article-title":"Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients","author":"Real","year":"2019","journal-title":"Mutat Res"},{"key":"10.1016\/j.clgc.2023.06.011_bib0032","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/s41388-020-01468-9","article-title":"EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer","volume":"39","author":"Lin","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.clgc.2023.06.011_bib0033","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fonc.2019.00325","article-title":"Identification of LIFR, PIK3R1, and MMP12 as novel prognostic signatures in gallbladder cancer using network-based module analysis","volume":"9","author":"Zhao","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12876-016-0499-z","article-title":"Leukotriene receptor expression in esophageal squamous cell cancer and non-transformed esophageal epithelium: a matched case control study","volume":"16","author":"Venerito","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0035","doi-asserted-by":"crossref","first-page":"13840","DOI":"10.1074\/jbc.M111.317131","article-title":"Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2","volume":"287","author":"Seo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clgc.2023.06.011_bib0036","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molmed.2019.02.005","article-title":"NIK as a druggable mediator of tissue injury","volume":"25","author":"Valino-Rivas","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.clgc.2023.06.011_bib0037","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12272-011-0109-0","article-title":"Biodistribution and improved anticancer effect of NIK-siRNA in combination with 5-FU for hepatocellular carcinoma","volume":"34","author":"Kang","year":"2011","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.clgc.2023.06.011_bib0038","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12885-019-5925-5","article-title":"NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12\/CXCR4 pathway","volume":"19","author":"Gao","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2023.06.011_bib0039","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/jid.2013.437","article-title":"SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway","volume":"134","author":"Wang","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clgc.2023.06.011_bib0040","doi-asserted-by":"crossref","first-page":"15966","DOI":"10.18632\/oncotarget.3862","article-title":"Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:37:13Z","timestamp":1761565033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1558767323001489"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.06.011","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}